Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF-Reference-Cited by-同舟云学术

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

Published:2021-01-18 Issue:4 Volume:23 Page:632-643
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Dewan Pooja¹,Docherty Kieran F.¹,Bengtsson Olof²,Boer Rudolf A.³,Desai Akshay S.⁴,Drozdz Jaroslaw⁵,Hawkins Nathaniel M.⁶,Inzucchi Silvio E.⁷,Kitakaze Masafumi⁸,Køber Lars⁹,Kosiborod Mikail N.¹⁰,Langkilde Anna Maria²,Lindholm Daniel²,Martinez Felipe A.¹¹,Merkely Béla¹²,Petrie Mark C.¹,Ponikowski Piotr¹³,Sabatine Marc S.¹⁴,Schou Morten¹⁵,Sjöstrand Mikaela²,Solomon Scott D.⁴,Verma Subodh¹⁶,Jhund Pardeep S.¹,McMurray John J.V.¹

Affiliation:

1. BHF Cardiovascular Research Centre University of Glasgow Glasgow UK

2. Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

3. Department of Cardiology University Medical Centre and University of Groningen Groningen The Netherlands

4. Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA USA

5. Department of Cardiology Medical University of Lodz Lodz Poland

6. Division of Cardiology University of British Columbia Vancouver Canada

7. Section of Endocrinology Yale University School of Medicine New Haven CT USA

8. Cardiovascular Division of Medicine National Cerebral and Cardiovascular Centre Osaka Japan

9. Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

10. Saint Luke's Mid America Heart Institute University of Missouri Kansas City MO USA

11. National University of Cordoba Cordoba Argentina

12. Heart and Vascular Centre Semmelweis University Budapest Hungary

13. Wroclaw Medical University Wroclaw Poland

14. TIMI Study Group Brigham and Women's Hospital and Harvard Medical School Boston MA USA

15. Department of Cardiology Gentofte University Hospital Copenhagen Denmark

16. St Michael's Hospital University of Toronto Toronto Canada

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2083

Reference29 articles.

1. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

2. Chronic Obstructive Pulmonary Disease and Heart Failure

3. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction

4. Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

5. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement;American Journal of Respiratory and Critical Care Medicine;2024-09-15

2. Chronic Obstructive Pulmonary Disease in Heart Failure: Challenges in Diagnosis and Treatment for HFpEF and HFrEF;Current Heart Failure Reports;2024-03-28

3. Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure;Journal of Clinical Medicine;2024-03-12

4. Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin;Journal of Clinical Medicine;2023-10-27

5. Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care;ESC Heart Failure;2023-10-03